The Risks of Prescription Drugs (A Columbia / SSRC Book (Privatization of Risk))

4 avg rating
( 5 ratings by Goodreads )
 
9780231146937: The Risks of Prescription Drugs (A Columbia / SSRC Book (Privatization of Risk))

Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions.

The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected.

Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs.

The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective.

Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks.

Additional Columbia / SSRC books on the privatization of risk and its implications for Americans:

Bailouts: Public Money, Private ProfitEdited by Robert E. Wright

Disaster and the Politics of InterventionEdited by Andrew Lakoff

Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker

Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman

Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein

"synopsis" may belong to another edition of this title.

About the Author:

Donald W. Light is professor of social medicine and comparative health care at the University of Medicine and Dentistry of New Jersey and a senior visiting researcher at Princeton.

Review:

The Risks of Prescription Drugs explains in clear, concise, and unflinching language the consequences of ignoring the discrepancy between the drug industry's private interests and the public service we hope and naïvely expect from them. This book provides consumers with tools for self-defense and concerned citizens with a road map for rebalancing American medicine. (John Abramson, Harvard Medical School, author of Overdosed America: The Broken Promise of American Medicine)

This volume introduces important debates on pharmaceutical promotion and marketing, needed drug evaluation and regulation, professional conflicts of interest, and increased medicalization of behavior. It explores important trends and policy questions that all engaged citizens should consider. (David Mechanic, Rutgers Institute for Health, Health Care Policy, and Aging Research, and author of The Truth About Health Care: Why Reform Is Not Working in America)

This is a sensible, readable and constructive book that could in various respects open the reader's eyes, and then lead him, with his eyes wide open, along the road to a healthier world. (M.N.G. Dukes International Journal of Risk and Safety in Medicine)

This well-referenced title will be of particular interest to prescribers, but I recommend it to all healthcare professionals. (Roger Evans Nursing Standard)

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 20.00
US$ 16.12

Convert Currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Published by Columbia University Press, United States (2010)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Paperback Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Columbia University Press, United States, 2010. Paperback. Book Condition: New. Language: English . Brand New Book. Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients health at greater risk, the effect of the expansion of disease categories, the industry s justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America s Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein. Bookseller Inventory # AAH9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 16.12
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Published by Columbia University Press, United States (2010)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Paperback Quantity Available: 10
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Columbia University Press, United States, 2010. Paperback. Book Condition: New. Language: English . Brand New Book. Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients health at greater risk, the effect of the expansion of disease categories, the industry s justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America s Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein. Bookseller Inventory # AAH9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 17.87
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Light, Donald W
Published by Columbia University Press (2010)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Softcover Quantity Available: 1
Rating
[?]

Book Description Columbia University Press, 2010. Book Condition: New. Editor(s): Light, Don. Series: Columbia / SSRC Book (Privatization of Risk). Num Pages: 184 pages, figures. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 208 x 142 x 11. Weight in Grams: 254. Series: Columbia / SSRC Book (Privatization of Risk). 184 pages, illustrations. Editor(s): Light, Don. Cateogry: (P) Professional & Vocational. BIC Classification: MMG. Dimension: 208 x 142 x 11. Weight: 254. . 2010. Paperback. . . . . . Bookseller Inventory # V9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 22.04
Convert Currency

Add to Basket

Shipping: FREE
From Ireland to U.S.A.
Destination, Rates & Speeds

4.

Light, Donald W
Published by Columbia University Press
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Softcover Quantity Available: 1
Seller:
Kennys Bookstore
(Olney, MD, U.S.A.)
Rating
[?]

Book Description Columbia University Press. Book Condition: New. Editor(s): Light, Don. Series: Columbia / SSRC Book (Privatization of Risk). Num Pages: 184 pages, figures. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 208 x 142 x 11. Weight in Grams: 254. Series: Columbia / SSRC Book (Privatization of Risk). 184 pages, illustrations. Editor(s): Light, Don. Cateogry: (P) Professional & Vocational. BIC Classification: MMG. Dimension: 208 x 142 x 11. Weight: 254. . 2010. Paperback. . . . . Books ship from the US and Ireland. Bookseller Inventory # V9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 22.22
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

5.

Donald W Light
Published by Columbia University Press
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Paperback Quantity Available: 1
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description Columbia University Press. Paperback. Book Condition: New. New copy - Usually dispatched within 2 working days. Bookseller Inventory # B9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 13.46
Convert Currency

Add to Basket

Shipping: US$ 9.17
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

D W Light
Published by University Press Group Ltd (2008)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Softcover Quantity Available: 1
Seller:
Rating
[?]

Book Description University Press Group Ltd, 2008. Book Condition: New. Bookseller Inventory # EH9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 20.30
Convert Currency

Add to Basket

Shipping: US$ 3.53
From Germany to U.S.A.
Destination, Rates & Speeds

7.

Published by Columbia University Press, United States (2010)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Paperback Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Columbia University Press, United States, 2010. Paperback. Book Condition: New. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients health at greater risk, the effect of the expansion of disease categories, the industry s justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America s Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein. Bookseller Inventory # BTE9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 24.12
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Light, D W
Published by Columbia University Press (2008)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Quantity Available: > 20
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Columbia University Press, 2008. PAP. Book Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Bookseller Inventory # WI-9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 12.25
Convert Currency

Add to Basket

Shipping: US$ 11.89
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Donald Light
Published by Columbia University Press (2011)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Softcover Quantity Available: 1
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Columbia University Press, 2011. Book Condition: New. book. Bookseller Inventory # ria9780231146937_rkm

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 20.10
Convert Currency

Add to Basket

Shipping: US$ 5.11
From United Kingdom to U.S.A.
Destination, Rates & Speeds

10.

Donald W Light
Published by Columbia University Press 2011-01-18, New York (2011)
ISBN 10: 0231146930 ISBN 13: 9780231146937
New Quantity Available: 5
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Columbia University Press 2011-01-18, New York, 2011. Book Condition: New. Bookseller Inventory # 9780231146937

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 17.90
Convert Currency

Add to Basket

Shipping: US$ 7.93
From United Kingdom to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book